Public health surveillance for methicillin-resistant Staphylococcus aureus: comparison of methods for classifying health care- and community-associated infections.

American Journal of Public Health
Dawn M SievertMatthew L Boulton

Abstract

We compared 3 methods for classifying methicillin-resistant Staphylococcus aureus (MRSA) infections as health care associated or community associated for use in public health surveillance. We analyzed data on MRSA infections reported to the Michigan Department of Community Health from October 1, 2004, to December 31, 2005. Patient demographics, risk factors, infection information, and susceptibility were collected for 2151 cases. We classified each case by the health care risk factor, infection-type, and susceptibility pattern methods and compared the results of the 3 methods. Demographic, clinical, and microbiological variables yielded similar health care-associated and community-associated distributions when classified by risk factor and infection type. When 2 methods yielded the same classifications, the overall distribution was similar to classification by 3 methods. No specific combination of 2 methods was superior. MRSA categorization by 2 methods is more accurate than it is by a single method. The health care risk factor and infection-type methods yield comparable classification results. Accuracy is increased by using more variables; however, further research is needed to identify the optimal combination.

References

Dec 1, 1992·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J M Boyce
Oct 1, 1992·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·A L PanlilioW J Martone
May 4, 1989·The New England Journal of Medicine·W Brumfitt, J Hamilton-Miller
Sep 1, 1982·Annals of Internal Medicine·R P Wenzel
Mar 5, 1998·JAMA : the Journal of the American Medical Association·B C HeroldR S Daum
Aug 26, 1998·The New England Journal of Medicine·F D Lowy
Aug 31, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T S NaimiK E Smith
Dec 25, 2002·Antimicrobial Agents and Chemotherapy·P D FeyP M Schlievert
Jun 25, 2003·Current Opinion in Infectious Diseases·John F Marcinak, Arthur L Frank
Dec 11, 2003·JAMA : the Journal of the American Medical Association·Timothy S NaimiRuth Lynfield
Jun 5, 2004·Clinics in Laboratory Medicine·Elizabeth Palavecino
Jun 18, 2004·Emerging Infectious Diseases·Craig E ZindermanBruce K Bohnker
Mar 16, 2005·Pharmacotherapy·Michael J Rybak, Kerry L LaPlante
Apr 9, 2005·The New England Journal of Medicine·Scott K FridkinUNKNOWN Active Bacterial Core Surveillance Program of the Emerging Infections Program Network
Nov 18, 2005·The Journal of Infection·B M W Diederen, J A J W Kluytmans
Dec 2, 2005·Emerging Infectious Diseases·Jessica M BuckRuth Lynfield
Dec 20, 2005·The Journal of Infectious Diseases·Matthew J KuehnertFred C Tenover
Feb 9, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Leonard B JohnsonLouis D Saravolatz
Aug 18, 2006·The New England Journal of Medicine·Gregory J MoranUNKNOWN EMERGEncy ID Net Study Group
Jan 24, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Loren G MillerBrad Spellberg
Oct 18, 2007·JAMA : the Journal of the American Medical Association·R Monina KlevensUNKNOWN Active Bacterial Core surveillance (ABCs) MRSA Investigators
Jan 8, 2008·Diagnostic Microbiology and Infectious Disease·Hsin HuangNeil M Flynn
Jan 25, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Ronald A HermanMary B Ross

❮ Previous
Next ❯

Citations

Mar 1, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A CanutA R Gascón
Mar 24, 2012·American Journal of Infection Control·William R JarvisRaymond Y Chinn
Sep 24, 2013·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Renata Tavares GomesCristiana Maria Nascimento-Carvalho
Nov 4, 2015·Antimicrobial Agents and Chemotherapy·A del RíoUNKNOWN Hospital Clinic Experimental Endocarditis Study Group
Jan 1, 2011·Journal of Rural Medicine : JRM·Hidenobu KawabataMasaji Maezawa

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.